To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.
DRAVP ID DRAVPa1854
Peptide Name Sequence 4 from Patent US20160346383 B2
Sequence RETVEREKE
Sequence Length 9
Source human ezrin protein
Target Organism encephalomyocarditis virus
Patent Type Granted Patent
Publication Date 2017-06-20
Patent No US20160346383 B2
Patent Title Ezrin-derived peptides and pharmaceutical compositions thereof
Comment
Abstract The present invention relates to the field of medicine, specifically, to the field of chemical and pharmaceutical industry and concerns ezrin-derived peptides, in particular, a peptide comprising an amino acid sequence of general formula (I) X1聽EKKRRETVERE X2X6, wherein each X represents a non-polar amino acid residue. The use of the peptides as immunostimulatory agents, and more specifically, for use in treating and preventing antiviral, antibacterial and antifungal infections, and treatment of diseases of the GI tract, in particular ulcerative disorders of the GI tract. The present invention also relates to pharmaceutical compositions comprising the peptides. Further, the invention relates to methods of treatment of infection and ulcerative diseases of the GI tract comprising administering the peptides to patients in need thereof.
To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.